Blanket Purchase Agreement 36C24126A0052
Award Date 9/30/26
Last Date to Order 9/29/31
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Veterans Integrated Service Network 6 established a Blanket Purchase Agreement with Cytopath Biopsy Lab Inc. on October 1, 2025, with a ceiling of $2,250,313 for ThyroSeq genomic testing services through September 30, 2030. ThyroSeq is a proprietary molecular diagnostic test that analyzes genetic mutations in thyroid nodules to assess cancer risk and support clinical decision-making for veterans. The BPA covers performance at multiple locations across VISN 6: Richmond, Salem, and Hampton,...
- Veterans Integrated Service Network 1 (VISN 1), a civilian component of the Department of Veterans Affairs, awarded a single-award Blanket Purchase Agreement valued at $2.88 million to Cytopath Biopsy Lab Inc. (operating as Cblpath) on September 30, 2021, with a performance period extending through September 29, 2026. The BPA establishes an indefinite delivery vehicle through which VISN 1 procures thyroid testing laboratory services to support cancer screening and diagnostic capabilities...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a Blanket Purchase Agreement (BPA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of ThyroSeq genomic classifier tests. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, and has held multiple federal contracts with the VA and Defense Health Agency to deliver ThyroSeq testing to support cancer screening and diagnosis programs for...
- Veterans Integrated Service Network 4 awarded a single-award indefinite delivery contract to Cytopath Biopsy Lab Inc. for laboratory testing services—thyroid (ThyroSeq)—with a ceiling of $372,990.00, effective June 1, 2026. The contract carries no set-aside designation. Place of performance is at the vendor's facility in Rye Brook, New York, supporting the Veterans Integrated Service Network 4 healthcare system. The contract procures molecular diagnostic laboratory testing services using...
- Veterans Integrated Service Network 12 awarded a single-award indefinite-delivery contract to Cytopath Biopsy Lab Inc. for ThyroSeq molecular diagnostic testing services, with a ceiling of $126,000 and an award date of April 1, 2022. The contract carries no set-aside designation. Work is performed in Port Chester, New York. The IDIQ supports cancer screening and diagnosis programs for veterans through genetic mutation analysis of thyroid nodules. The period of performance extends through March...
- Veterans Integrated Service Network 19 of the Department of Veterans Affairs established a Blanket Purchase Agreement with Cytopath Biopsy Lab Inc. (doing business as Cblpath) on September 1, 2023, with a ceiling of $360,000.00 and an ultimate completion date of August 31, 2026. The BPA procures ThyroSeq molecular diagnostic testing services, a proprietary genetic testing platform that analyzes mutations in thyroid nodules to assess cancer risk and support clinical decision-making for veteran...
- Veterans Integrated Service Network 2 awarded a single-award indefinite-delivery contract to Cytopath Biopsy Lab Inc. (doing business as Cblpath) on February 13, 2023, with a ceiling of $1.8 million for ThyroSequence testing services. The contract carries no set-aside designation. Place of performance is New York, New York. The IDIQ procures molecular diagnostic laboratory testing services, specifically ThyroSeq genomic sequencing analysis of thyroid nodules to assess cancer risk and support...
- Veterans Integrated Service Network 21 awarded an indefinite-delivery contract to Cytopath Biopsy Lab Inc. on August 7, 2023, with a $500,000 ceiling for ThyroSeq laboratory tests to determine thyroid nodule malignancy in surgical decisions. This is a single-award contract with no set-aside. Performance occurs in San Francisco, California. The contract runs through August 6, 2028, with a base period and options structure. The originating solicitation, posted May 18, 2023 with a May 29, 2023...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a single award indefinite delivery contract to Cytopath Biology Lab Inc. to provide cytopathology and ThyroSeq testing services. Under the contract, Cytopath Biology Lab Inc. leverages its Cblpath division to conduct diagnostic pathology testing at its laboratory in Lebanon, Pennsylvania. Three firm fixed price delivery orders have been issued against the contract to date, valued at...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a blanket purchase agreement to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide molecular thyroid mutation reference testing services. The solicitation aimed to procure specialized diagnostic testing to help determine if thyroid nodules detected in veterans were benign or malignant. Under the IDV, Cblpath has received four firm fixed price call orders totaling $372,000...